Table 1.
SBP | DBP | PP | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Gene a | NVARb | BurdenVT c | BurdenCMC c | SKAT c | BurdenVT | BurdenCMC | SKAT | BurdenVT | BurdenCMC | SKAT |
CFS-EA Coding, N = 395 | ||||||||||
RBFOX1 | 3 | 0.012 | 0.456 | 0.024 | 0.11 | 0.342 | 0.064 | 0.001 | 0.042 | 0.014 |
SLX4 | 10 | 0.12 | 0.851 | 0.056 | 0.16 | 0.569 | 0.035 | 0.52 | 0.687 | 0.572 |
CFS-EA Non-coding, N = 395 | ||||||||||
MTRNR2L4 | 2 | 0.05 | 0.048 | 0.101 | 0.012 | 0.01 | 0.027 | 0.55 | 0.576 | 0.8 |
RBFOX1 | 86 | 0.95 | 0.71 | 0.036 | 0.29 | 0.213 | 0.257 | 0.59 | 0.566 | 0.114 |
SLX4 | 3 | 0.22 | 0.11 | 0.107 | 0.022 | 0.009 | 0.007 | 0.99 | 0.931 | 1 |
CFS-EA Coding + Non-coding, N = 395 | ||||||||||
MTRNR2L4 | 2 | 0.045 | 0.048 | 0.101 | 0.013 | 0.010 | 0.027 | 0.550 | 0.576 | 0.800 |
RBFOX1 | 89 | 0.890 | 0.323 | 0.036 | 0.340 | 0.571 | 0.266 | 0.230 | 0.044 | 0.087 |
SLX4 | 13 | 0.034 | 0.851 | 0.047 | 0.006 | 0.569 | 0.003 | 0.690 | 0.687 | 0.861 |
EA Meta-Analysis Coding, N = 18,025 | ||||||||||
RBFOX1 | 3 | 0.051 | 0.021 | 0.478 | 0.042 | 0.025 | 0.308 | 0.554 | 0.320 | 0.546 |
SLX4 | 10 | 0.086 | 0.069 | 0.071 | 0.599 | 0.901 | 0.301 | 0.004 | 0.001 | 0.021 |
EA Meta-Analysis Non-coding, N = 18,025 | ||||||||||
MTRNR2L4 | 2 | 0.002 | 0.685 | 0.085 | 0.013 | 0.853 | 0.446 | 0.037 | 0.531 | 0.075 |
RBFOX1 | 86 | 0.384 | 0.926 | 0.032 | 0.712 | 0.98 | 0.091 | 0.624 | 0.94 | 0.493 |
SLX4 | 3 | 0.379 | 0.493 | 0.649 | 0.995 | 0.908 | 0.986 | 0.046 | 0.091 | 0.151 |
EA Meta-Analysis Coding + Noncoding, N = 18,025 | ||||||||||
MTRNR2L4 | 2 | 0.002 | 0.685 | 0.085 | 0.013 | 0.853 | 0.446 | 0.035 | 0.531 | 0.075 |
RBFOX1 | 89 | 0.222 | 0.007 | 0.009 | 0.078 | 0.037 | 0.013 | 0.630 | 0.126 | 0.598 |
SLX4 | 13 | 0.071 | 0.093 | 0.086 | 0.917 | 0.554 | 0.621 | 2.19E-04 | 0.006 | 0.009 |
Gene: only genes with at least 1 gene-based test p < 0.05 in stage I discovery analysis were moved forward for stage I replication
NVAR: number of passed variants; only include linkage-based selected functional coding variants and rare non-coding variants with MAF < 1%, CADD > 10
BurdenVT, BurdenCMC, and SKAT are gene-based tests described in the Methods section.